The CRO concept continued to rise in the intraday market. Nanmo Biotech rose and stopped 20 cm. Previously, Broji Pharmaceuticals rose 20 cm, Wanbang Pharmaceutical rose 18%, and nearshore protein, Haoyuan Pharmaceuticals, Wisdom Pharmaceuticals, Opumai, and Bioosetu registered higher gains.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.